title: A pediatric case of severe proteinuric purpura nephritis with predominantly subepithelial IgA deposits.
authors.forename: K
authors.initials: K
authors.lastname: Tsuruga
authors.forename: I
authors.initials: I
authors.lastname: Hanada
authors.forename: E
authors.initials: E
authors.lastname: Oki
authors.forename: K
authors.initials: K
authors.lastname: Suzuki
authors.forename: E
authors.initials: E
authors.lastname: Ito
authors.forename: T
authors.initials: T
authors.lastname: Echizenya
authors.forename: H
authors.initials: H
authors.lastname: Tanaka
mesh_terms: D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011695:IgA Vasculitis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D007070:Immunoglobulin A; D007074:Immunoglobulin G / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000276:immunology / Q000473:pathology; D009393:Nephritis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D005938:Glucocorticoids; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone